Page last updated: 2024-11-05

thalidomide and Erythroblastosis Fetalis

thalidomide has been researched along with Erythroblastosis Fetalis in 3 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
WALKER, J1
Tuli, SM1
Wolf, HG1

Reviews

2 reviews available for thalidomide and Erythroblastosis Fetalis

ArticleYear
ADVANCES IN OBSTETRICS AND GYNAECOLOGY.
    The Practitioner, 1963, Volume: 191

    Topics: Anemia; Endocrinology; Erythroblastosis, Fetal; Female; Genital Neoplasms, Female; Gynecology; Hormo

1963
Certain causes of congenital malformations in Homo sapiens and their prevention.
    Journal of the Indian Medical Association, 1967, Dec-01, Volume: 49, Issue:11

    Topics: Abnormalities, Drug-Induced; Abortion, Therapeutic; Aminopterin; Antigen-Antibody Reactions; Chromos

1967

Other Studies

1 other study available for thalidomide and Erythroblastosis Fetalis

ArticleYear
[Prenatal and neonatal drug-induced lesions].
    Wiener klinische Wochenschrift, 1968, Jun-21, Volume: 80, Issue:25

    Topics: Abnormalities, Drug-Induced; Adult; Androgens; Drug-Related Side Effects and Adverse Reactions; Eryt

1968